Truist Securities analyst Brandon King maintains Seacoast Banking (NASDAQ:SBCF) with a Buy and lowers the price target from $42 to $39.
Where Seres Therapeutics Stands With Analysts
Over the past 3 months, 7 analysts have published their opinion on Seres Therapeutics (NASDAQ:MCRB) stock. These analysts…